Insights from 2023 ASH Annual Meeting
Playback speed
10 seconds
ASH 2023 Insights: "COVALENT-101 Study - Covalent Menin Inhibitor BMF-219 in Patients With R/R Acute Leukemia"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Jeffrey Lancet
By
Insights from 2023 ASH Annual Meeting
FEATURING
Jeffrey Lancet
74 views
December 27, 2023
Login to view comments.
Click here to Login
Leukemia